Esperion Therapeutics News (NASDAQ:ESPR)

Add to My Stocks
$45.75 $0.18 (0.39%) ESPR stock closing price Sep 20, 2018 (Closing)
Esperion Prices Public Offering of Common Stock   by Globe Newswire on Aug 09, 2017

ESPR Industry Peers

Company Price Change (%)
Immunogen (IMGN)9.240.42 (4.76%)
Endocyte (ECYT)17.630.09 (0.51%)
Abbvie (ABBV)92.681.66 (1.82%)
Merck (MRK)70.780.8 (1.14%)
Alnylam Pharma (ALNY)95.210.39 (0.41%)
Amgen (AMGN)205.11.9 (0.94%)
The Medicines Company (MDCO)34.490.89 (2.65%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
PYXUS INTL INC (PYX)26.15.7 (27.94%)
Acadia Pharma (ACAD)19.114.01 (26.56%)
Conatus Pharma (CNAT)5.540.82 (17.37%)
Mechel PAO (MTL)3.420.5 (17.12%)
American Superconductor (AMSC)7.331.02 (16.16%)
Galectin Therapeutics (GALT)6.930.88 (14.55%)
Kandi Technologies (KNDI)5.650.7 (14.14%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 21, 2018
CompanyPriceChange (%)
OncoMed Pharma (OMED)2.40.4 (14.29%)
Thor Industries (THO)91.9513.69 (12.96%)
Seaspan (SSW)8.210.95 (10.37%)
Willian Lyon Homes (WLH)17.21.45 (7.77%)
Golden Entertainment (GDEN)24.732.08 (7.76%)
Rigel Pharma (RIGL)3.320.27 (7.52%)
MOLECULAR TEMPL (MTEM)5.790.46 (7.36%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 21, 2018